Top 5 Art VC (Venture Capital) Funds in Singapore in February 2025

Last updated: Feb 2025 A list of 5 VC (Venture Capital) funds that invest in Art startups based in Singapore. We rank investors based on the number of investments they made in Art companies from Singapore. We update this investor list every month.

Top 5 Art VC (Venture Capital) Funds in Singapore in February 2025

Investor	Art Singapore investments
Antler	2
iGlobe Partners	1
East Ventures	1
Susquehanna International Group (SIG)	1
Alameda Research	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Investment focus

Software, Information Technology, SaaS
Pre-Seed, Seed, Series A
Singapore, United Kingdom, Australia

Portfolio highlights

Immibot — Get assistance from our AI-powered chatbot on your immigration journey. Our model is trained on official regulations to answer any questions you may have on how to move abroad.
Quench.ai — Quench is a tech infrastructure for video creators to deliver exclusive content, engage and reward their true fans.
Source — Source is an AI-powered recruitment platform that makes tech talent sourcing fast, precise, and cost-effective.

We are a Venture Capital firm based in Singapore with a strong proven track record. We have assisted our companies to successful globalisation and exits over multiple business cycles. Our Funds focus on Smart Cities, FinTech, Digital Media and Extended Reality.

Investment focus

Health Care, Software, Biotechnology
Series A, Series B, Series C
United States, Singapore, United Kingdom

Portfolio highlights

Docquity — Exchange ideas with the best doctors in the region. Receive educational resources designed by well known and respected leaders. Attend virtual discussions
Orbital Therapeutics — Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines to treat human disease in ways that were not previously possible.
Accession Therapeutics — Accession Therapeutics’ elegant Trocept platform has potential to treat some of the most intractable and widespread forms of cancer. Based in Oxford, UK, it is developing a pipeline of products to the early clinical trial stage. Led by Bent Jakobsen, PhD FMedSci, a pioneer of T cell receptor therapy for cancer, the team is highly experienced intaking immuno-oncology products to the clinic. Accession Therapeutics’ Trocept technology is based on over a decade’s work and has generated exceptional preclinical data.Accession Therapeutics’ proprietary technology incorporates cancer-tropic viruses, the first time that viruses have been genetically modified to exclusively target cancer cells. As non-cancerous cells are not targeted by Trocept, systemic toxicity is eliminated meaning the drugs can be delivered intravenously and traffic to the tumour. Trocept’s highly potent and local activity gives it potential in some of the hardest to treat and most widespread forms of cancer. This includes breast, cervical, colorectal, gastric, head and neck, lung, oral, ovarian and pancreatic cancer.

East Ventures is an early stage venture capital (VC) focused on Southeast Asia, Indonesia & Japan. Success cases include Tokopedia, Traveloka, and Mercari.

Investment focus

Software, Information Technology, E-Commerce
Seed, Series A, Funding Round
Japan, Indonesia, Singapore

Portfolio highlights

SoLeLands — SoLeLands provides children with future-ready skills, virtues, and applied competences and inspires children to love learning.
Maka Motors — MAKA is dedicated to building the best electric motorcycles for Indonesian riders.
Zenith Learning Group — Zenith Learning Group's mission is to deliver a holistic, world-class education to learners across South East Asia through technology.

Discover Susquehanna, a global quantitative trading firm built on a rigorous, analytical foundation in financial markets.

Investment focus

Software, Financial Services, Internet
Series A, Series B, Funding Round
United States, China, Singapore

Portfolio highlights

zkLink — zkLink is a unified middleware layer connecting L1 chains and L2 networks with zk-SNARKs technology, reshaping the crypto landscape for DeFi, NFT, and RWA trading.
Percent — Unlock private credit investments with Percent. Access alternative investments on the platform powering the future of private markets.
Wakefit — Buy mattress and pillows online at best price. Select from wide range of single, double, king size and queen size mattresses. *100 nights risk free trial *10 year warranty *COD *Free Shipping

Alameda Research is a quantitative cryptocurrency trading firm that provides liquidity in cryptocurrency and digital assets markets. It was founded in 2017 and is headquartered in Central and Western, Hong Kong.